Molecular disorganization of axons adjacent to human lacunar infarcts

Brain

Volumn 138, Issue 3, 2015, Pages 736-745

  Hinman, Jason D ^a   Lee, Monica D ^a   Tung, Spencer ^b   Vinters, Harry V ^a,b   Thomas Carmichael, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ion channels; Lacunar stroke; Neuropathology; Small vessel disease; Vascular dementia

Indexed keywords

MYELIN BASIC PROTEIN; CNTNAP1 PROTEIN, HUMAN; NERVE CELL ADHESION MOLECULE; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; SPECTRIN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN INFARCTION SIZE; BRAIN REGION; CELL ADHESION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; LACUNAR STROKE; LEUKOENCEPHALOPATHY; MALE; MIDDLE AGED; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROFILAMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PRIORITY JOURNAL; RANVIER NODE; RETINOPATHY; RETROSPECTIVE STUDY; VERY ELDERLY; WHITE MATTER; WHITE MATTER INJURY; BRAIN; CITRULLINEMIA; COMPLICATION; METABOLISM; MYELINATED NERVE; PATHOLOGY;

AGED; AGED, 80 AND OVER; AXONS; BRAIN; CELL ADHESION MOLECULES, NEURONAL; CITRULLINEMIA; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELIN BASIC PROTEIN; NERVE FIBERS, MYELINATED; NEUROFILAMENT PROTEINS; RANVIER'S NODES; SPECTRIN; STROKE, LACUNAR;

EID: 84927971251     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu398     Document Type: Article

References (44)

1. Arsava EM, Bayrlee A, VAngel M, Rost NS, Rosand J, Furie KL, et al. Severity of leukoaraiosis determines clinical phenotype after brain infarction. Neurology 2011; 77: 55-61.
2. Bailey EL, Smith C, Sudlow CL, Wardlaw JM. Pathology of lacunar ischaemic stroke in humans-a systematic review. Brain Pathol 2012; 22: 583-91.
3. Bastin ME, Clayden JD, Pattie A, Gerrish IF, Wardlaw JM, Deary IJ. Diffusion tensor and magnetization transfer MRI measurements of periventricular white matter hyperintensities in old age. Neurobiol Aging 2009; 30: 125-36.
4. Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, St Martin M, et al. Axon-glia interactions and the domain organization of mye-linated axons requires neurexin IV/Caspr/Paranodin. Neuron 2001; 30: 369-83.
5. Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, Ranscht B. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 2001; 30: 385-97.
6. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab 2012; 32: 425-36.
7. Conijn MM, Kloppenborg RP, Algra A, Mali WP, Kappelle LJ, Vincken KL, et al. Cerebral small vessel disease and risk of death, ischaemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study. Stroke 2011; 42: 3105-9.
8. Coutts SB, Modi J, Patel SK, Aram H, Demchuk AM, Goyal M, Hill MD. What causes disability after transient ischaemic attack and minor stroke?: results from the CT and MRI in the triage of TIA and minor Cerebrovascular events to identify high risk patients (CATCH) study. Stroke 2012; 43: 3018-22.
9. Decarli C. Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals. J Alzheimer's Dis 2013; 33 (Suppl 1): S417-26.
10. Duering M, Csanadi E, Gesierich B, Jouvent E, Herve D, Seiler S, et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain 2013; 136: 2717-26.
11. Dupree JL, Girault JA, Popko B. Axo-glial interactions regulate the localization of axonal paranodal proteins. J Cell Biol 1999; 147: 1145-52.
12. Einheber S, Zanazzi G, Ching W, Scherer S, Milner TA, Peles E, et al. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 1997; 139: 1495-506.
13. Fernando MS, O'brien JT, Perry RH, English P, Forster G, Mcmeekin W, et al. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 2004; 30: 385-95.
14. Ferrer I, Kaste M, Kalimo H. Consequences of cerebrovascular disorders. In: Love S, Louis D, Ellison DW, editors. Greenfield's neuro-pathology. 8th edn. Boca Raton, FL: CRC Press; 2008.
15. Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982; 32: 871-6.
16. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American heart association. Circulation 2014; 129: e28-e292.
17. Gouw AA, Van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39: 1414-20.
18. Herrero-Herranz E, Pardo LA, Gold R, Linker RA. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 2008; 30: 162-73.
19. Hinman JD, Peters A, Cabral H, Rosene DL, Hollander W, Rasband MN, et al. Age-related molecular reorganization at the node of Ranvier. J Comp Neurol 2006; 495: 351-62.
20. Holland PR, Bastin ME, Jansen MA, Merrifield GD, Coltman RB, Scott F, et al. MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice. Neurobiol Aging 2011; 32: 2325 e1-6.
21. Howell OW, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C, et al. Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 2006; 129: 3173-85.
22. Jen J, Cohen AH, Yue Q, Stout JT, Vinters HV, Nelson S, et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997; 49: 1322-30.
23. Kolar GR, Kothari PH, Khanlou N, Jen JC, Schmidt RE, Vinters HV. Neuropathology and genetics of cerebroretinal vasculopathies. Brain Pathol 2014; 24: 510-8.
24. Maillard P, Fletcher E, Harvey D, Carmichael O, Reed B, Mungas D, et al. White matter hyperintensity penumbra. Stroke 2011; 42: 1917-22.
25. Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, Fischer U, et al. Outcome of stroke with mild or rapidly improving symptoms. Stroke 2007; 38: 2531-5.
26. Okamoto Y, Ihara M, Fujita Y, Ito H, Takahashi R, Tomimoto H. Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia. Neuroreport 2009; 20: 990-6.
27. Pillai AM, Thaxton C, Pribisko AL, Cheng JG, Dupree JL, Bhat MA. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains. J Neurosci Res 2009; 87: 1773-93.
28. Reimer MM, Mcqueen J, Searcy L, Scullion G, Zonta B, Desmazieres A, et al. Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J Neurosci 2011; 31: 18185-94.
29. Richards A, Van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, et al. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vascu-lopathy with cerebral leukodystrophy. Nat Genet 2007; 39: 1068-70.
30. Rios JC, Melendez-Vasquez CV, Einheber S, Lustig M, Grumet M, Hemperly J, et al. Contactin-associated protein (Caspr) and contac-tin form a complex that is targeted to the paranodal junctions during myelination. J Neurosci 2000; 20: 8354-64.
31. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the American heart association. Circulation 2012; 125: e2-e220.
32. Schafer DP, Rasband MN. Glial regulation of the axonal membrane at nodes of Ranvier. Curr Opin Neurobiol 2006; 16: 508-14.
33. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischaemic stroke. Stroke 2005; 36: 2497-9.
34. Smith EE, Fonarow GC, Reeves MJ, Cox M, Olson DM, Hernandez AF, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plas-minogen activator: findings from Get With The Guidelines-Stroke. Stroke 2011; 42: 3110-5.
35. Sonohara K, Kozaki K, Akishita M, Nagai K, Hasegawa H, Kuzuya M, et al. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly. Geriatr Gerontol Int 2008; 8: 93-100.
36. Susuki K, Chang KJ, Zollinger DR, Liu Y, Ogawa Y, Eshed-Eisenbach Y, et al. Three mechanisms assemble central nervous system nodes of Ranvier. Neuron 2013; 78: 469-82.
37. Susuki K, Rasband MN. Molecular mechanisms of node of Ranvier formation. Curr Opin Cell Biol 2008; 20: 616-23.
38. Tait S, Gunn-Moore F, Collinson JM, Huang J, Lubetzki C, Pedraza L, et al. An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol 2000; 150: 657-66.
39. van Veluw SJ, Zwanenburg JJ, Engelen-Lee J, Spliet WG, Hendrikse J, Luijten PR, et al. In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI. J Cereb Blood Flow Metab 2013; 33: 322-9.
40. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam scan study. Stroke 2003; 34: 1126-9.
41. Vermeer SE, Longstreth WT, Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6: 611-9.
42. Wardlaw JM, Farrall A, Armitage PA, Carpenter T, Chappell F, Doubal F, et al. Changes in background blood-brain barrier integrity between lacunar and cortical ischaemic stroke subtypes. Stroke 2008; 39: 1327-32.
43. Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001; 81: 263-81.
44. Zollinger LV, Kim TH, Hill K, Jeong EK, Rose JW. Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. J Magn Reson Imaging 2011; 33: 557-64.